Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: ROCHE DIAGNOSTICS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2019-10-01 to 2022-09-30
Current total value of award: $1193284.11
Description: CANCER ANTIBODIES REAGENTS - EO14042 AND FY22 FUNDING